Equine Precision Therapy
Timeline
9 events since 2023Filings
Financial
Establishments
2023202420252026
The 2026 accounts are due by 31-07-2027.
2026
Annual accounts 2025 filed NBBmicro format · 14 days late
2025
Highest result from 2023 to 2025 net €98,879 ▲36.2% The operating result of €130,006 and the net result of €98,879 are both a record.
Equity above €200,000 equity €222,668 ▲79.9% With a profit in every financial year since 2023, equity grows to €222,668.
Registered in the Peppol Directory Reachable for e-invoices through 0208:0797728295
Annual accounts 2024 filed PDFmicro format · 34 days before the deadline
2024
Equity above €100,000 equity €123,788 ▲142% With a profit in every financial year since 2023, equity grows to €123,788.
Annual accounts 2023 filed PDFmicro format · 12 days late
2023
IncorporationFounding capital of €2,000, 20 shares · Founded by and · (director) and (director) appointed · published on 31-01-20237 points ▸
- Registered office clause, Gembloux (5032 Mazy), Chaussée de Nivelles 15
- Director appointment, (director (not named in the articles))
- Director appointment, (director (not named in the articles))
- Founder,
- Founder,
- Founding capital, €2,000, 20 shares
- 20 shares
- The deed holds 5 more points.
First establishment Chaussée de Nivelles, Mazy 15, Gembloux
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank